# NRX Pharmaceuticals, Inc.: Form S-1, filed Nov 14, 2024

- Company: [NRX Pharmaceuticals, Inc.](/companies/nrxp.md) (CIK 1719406)
- Form: S-1
- Filed: 2024-11-14
- Accepted by EDGAR: Nov 14, 2024, 12:21 ET
- Period: not reported
- Accession: 0001437749-24-035167
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1719406/000143774924035167/nrxp20241112_s1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1719406/000143774924035167/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1719406/000143774924035167/nrxp20241112_s1.htm

Filed Nov 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-035167. Last ingested by Listed: Nov 4, 2026, 20:02 ET. No prices; not investment advice.